Welcome to our dedicated page for Doximity SEC filings (Ticker: DOCS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Doximity filings document financial results, material events, governance actions, and capital-structure details for the operator of a digital platform for U.S. medical professionals. Recent Form 8-K disclosures cover quarterly results and related exhibits, finance and legal leadership changes, Regulation FD updates, and annual-meeting voting outcomes.
The company's regulatory record also includes shareholder voting matters tied to its Class A and Class B common stock structure, director elections, auditor ratification, material agreements, and other security-holder matters. These filings describe how Doximity reports operating performance, governance changes, voting mechanics, and formal public-company events.
Doximity, Inc. (DOCS) has an officer, Siddharth Sitaram, providing notice under Rule 144 of a proposed sale of 2,077 shares of common stock through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $54,043.54. The notice states that 127,349,369 shares of Doximity common stock are outstanding and lists the NYSE as the exchange.
The shares to be sold are shown as being acquired on September 15, 2026 via a stock option exercise, with cash as the form of payment. The notice also reports that Siddharth Sitaram sold 1,770 shares for $44,143.80 on August 13, 2026 and 1,732 shares for $38,138.64 on July 15, 2026.
Doximity, Inc. (DOCS) director Kira Scherer Wampler reported an option exercise and related share sale. On September 1, 2026, she exercised options for 2,000 shares of Class B Common Stock at an exercise price of $1.54 per share, leaving 443,700 options outstanding from that grant. The 2,000 Class B shares converted into 2,000 Class A shares, which were then sold at $26.33 per share pursuant to a Rule 10b5-1 trading plan.
Doximity, Inc. (DOCS) reported the results of its 2026 Annual Meeting of Stockholders held on August 27, 2026. Common stockholders representing 614,551,986 votes, or 96.34% of votes entitled to be cast, were present in person or by proxy, constituting a quorum. Stockholders elected Class II directors Kevin Spain and Timothy Cabral to serve until the 2029 annual meeting, with Spain receiving 534,599,583 votes for and Cabral 587,108,878 votes for. Stockholders also ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending March 31, 2027, with 610,837,373 votes for. In a non-binding advisory vote, stockholders approved executive compensation for the fiscal year ended March 31, 2026, with 555,836,605 votes for and 33,841,608 against.
Doximity, Inc. (DOCS) received a Rule 144 notice from Kira Wampler, a director, regarding a planned sale of common stock. The notice covers 2,000 shares of common stock underlying options to be exercised for cash, with an indicated aggregate market value of $52,660.00. Doximity had approximately 127,349,369 shares outstanding of common stock, and the shares trade on the NYSE. The filing also lists a prior sale of 2,000 shares of Doximity common stock on August 25, 2026.
Doximity, Inc. (symbol: DOCS) is the issuer of record for a Form 4 filing submitted to the SEC.
Doximity, Inc. (symbol: DOCS) is the issuer of record for a Form 4 filing submitted to the SEC.
Doximity, Inc. (symbol: DOCS) is the issuer of record for a Form 4 filing submitted to the SEC.
Doximity, Inc. (symbol: DOCS) is the issuer of record for a Form 4 filing submitted to the SEC.
Doximity, Inc. (symbol: DOCS) is the issuer of record for a Form 4 filing submitted to the SEC.
Doximity, Inc. (DOCS) director Kira Scherer Wampler reported a series of related transactions involving 2,000 shares on August 25, 2026. A vested stock option to purchase 2,000 shares of Class B Common Stock at an exercise price of $1.54 per share was exercised, and those Class B shares were converted into 2,000 shares of Class A Common Stock. The 2,000 Class A shares were then sold at $24.95 per share in a transaction made automatically under a Rule 10b5-1 trading plan adopted on May 26, 2026. Following the option exercise, Wampler held 445,700 stock options directly.